ARRAY BIOPHARMA INC Contracts & Agreements

First Supplemental Indenture, dated July 30, 2019, between Array BioPharma Inc., Pfizer Inc. and The Bank of New York Mellon Trust Company, N.A (Filed With SEC on July 30, 2019)

Agreement and Plan of Merger, dated June 14, 2019, among Array BioPharma Inc., Pfizer Inc. and Arlington Acquisition Sub Inc (Filed With SEC on June 17, 2019)

Separation Agreement, dated March 19, 2019, between registrant and Curtis Oltmans (Filed With SEC on May 7, 2019)

Sales Agreement between Array BioPharma Inc. and Jefferies LLC dated May 7, 2019 (Filed With SEC on May 7, 2019)

Amended and Restated Loan Agreement dated August 10, 2018 between the registrant and Silicon Valley Bank (Filed With SEC on August 14, 2018)

Sales Agreement between Array BioPharma Inc. and Cantor Fitzgerald & Co. dated May 9, 2018 (Filed With SEC on May 9, 2018)

License Agreement, dated January 3, 2018, between the registrant and ASLAN Pharmaceuticals Pte. Ltd (Filed With SEC on February 6, 2018)

Indenture, dated as of December 1, 2017, by and between Array BioPharma Inc. and The Bank of New York Mellon Trust Company, N.A (Filed With SEC on December 4, 2017)

Form of Exchange Agreement (Filed With SEC on November 17, 2017)

Underwriting Agreement, dated September 14, 2017, by and between Array BioPharma Inc. and J.P. Morgan Securities LLC, as representative of the several Underwriters named therein (Filed With SEC on September 15, 2017)

ARRAY BIOPHARMA INC. DESCRIPTION OF PERFORMANCE BONUS PROGRAM (Filed With SEC on August 28, 2017)

LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (Filed With SEC on August 11, 2017)

CLINICAL TRIAL COLLABORATION AND SUPPLY AGREEMENT by and between Merck Sharp & Dohme B.V., and Array BioPharma, Inc. Dated: May 4, 2017 (Filed With SEC on August 11, 2017)

SECOND AMENDMENT TO LEASE (Filed With SEC on August 11, 2017)

ARRAY BIOPHARMA INC. FIRST AMENDMENT TO SUBORDINATED CONVERTIBLEPROMISSORY NOTES (Filed With SEC on August 9, 2017)

LOAN AND SECURITY AGREEMENT (Filed With SEC on December 23, 2016)

Array BioPharma Inc. 18,400,000 Shares of Common Stock Underwriting Agreement (Filed With SEC on September 28, 2016)

SUBORDINATED CONVERTIBLE PROMISSORY NOTE (Filed With SEC on September 2, 2016)

NOTE PURCHASE AGREEMENT (Filed With SEC on September 2, 2016)

FOURTEENTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on September 2, 2016)

THIRTEENTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on August 19, 2016)

EMPLOYMENT AGREEMENT (Filed With SEC on August 19, 2016)

NONCOMPETE AGREEMENT (Filed With SEC on August 19, 2016)

CONFIDENTIALITY AND INVENTIONS AGREEMENT (Filed With SEC on August 19, 2016)

ARRAY BIOPHARMA INC. DESCRIPTION OF PERFORMANCE BONUS PROGRAM (Filed With SEC on August 3, 2016)

AMENDED AND RESTATED DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (Filed With SEC on February 5, 2016)

EMPLOYMENT AGREEMENT (Filed With SEC on November 6, 2015)

NONCOMPETE AGREEMENT (Filed With SEC on November 6, 2015)

CONFIDENTIALITY AND INVENTIONS AGREEMENT (Filed With SEC on November 6, 2015)

ARRAY BIOPHARMA INC. CONTROLLED EQUITY OFFERINGSM AMENDMENT NO. 3 TO SALES AGREEMENT (Filed With SEC on November 6, 2015)

TWELFTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on November 6, 2015)

ARRAY BIOPHARMA INC. DESCRIPTION OF PERFORMANCE BONUS PROGRAM (Filed With SEC on August 24, 2015)

AMENDMENT NO. 4 TO DRUG DISCOVERY COLLABORATION AGREEMENT (Filed With SEC on August 21, 2015)

ASSET PURCHASE AGREEMENT BY AND BETWEEN ACCURATUS LAB SERVICES, INC. (Buyer) AND ARRAY BIOPHARMA INC. (Seller) ___________________ June1, 2015 ___________________ (Filed With SEC on August 21, 2015)

FIRST AMENDMENT TO AND PARTIAL TERMINATION OF LEASE (Filed With SEC on August 21, 2015)

ELEVENTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on August 21, 2015)

LGX818 ASSET TRANSFER AGREEMENT by and between NOVARTIS PHARMA AG and ARRAY BIOPHARMA INC. Dated as of January 19, 2015 (Filed With SEC on May 7, 2015)

FIRST AMENDMENT TO TERMINATION AND ASSET TRANSFER AGREEMENT (Filed With SEC on May 7, 2015)

SEVENTH AMENDMENT TO DRUG DISCOVERY COLLABORATION AGREEMENT (Filed With SEC on May 7, 2015)

TRANSITION AGREEMENT (Filed With SEC on May 7, 2015)

AMENDMENT NO. 3 TO DRUG DISCOVERY COLLABORATION AGREEMENT (Filed With SEC on February 4, 2015)

TERMINATION AND ASSET TRANSFER AGREEMENT by and between NOVARTIS PHARMA AG, NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. and ARRAY BIOPHARMA INC. Dated as of November26, 2014 (Filed With SEC on February 4, 2015)

LICENSE AGREEMENT (Filed With SEC on February 4, 2015)

EMPLOYMENT AGREEMENT (Filed With SEC on September 12, 2014)

NONCOMPETE AGREEMENT (Filed With SEC on September 12, 2014)

CONFIDENTIALITY AND INVENTIONS AGREEMENT (Filed With SEC on September 12, 2014)

EMPLOYMENT AGREEMENT (Filed With SEC on September 12, 2014)

ARRAY BIOPHARMA INC. DESCRIPTION OF PERFORMANCE BONUS PROGRAM (Filed With SEC on August 20, 2014)

Array BioPharma Inc. Notice of Grant of Restricted Stock Units (Filed With SEC on August 20, 2014)

AMENDMENT NO. 1 TO DRUG DISCOVERY COLLABORATION AGREEMENT (Filed With SEC on August 15, 2014)

AMENDMENT NO. 2 TO DRUG DISCOVERY COLLABORATION AGREEMENT (Filed With SEC on August 15, 2014)

EMPLOYMENT AGREEMENT (Filed With SEC on August 15, 2014)

TENTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on February 5, 2014)

DRUG DISCOVERY AND DEVELOPMENT OPTION AND LICENSE AGREEMENT (Filed With SEC on November 1, 2013)

DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (Filed With SEC on August 12, 2013)

ARTICLE 1DRUG DISCOVERY COLLABORATION AGREEMENT (Filed With SEC on August 12, 2013)

ARRAY BIOPHARMA INC. DESCRIPTION OF PERFORMANCE BONUS PROGRAM (Filed With SEC on August 12, 2013)

Array BioPharma Inc. 3.00% Convertible Senior Notes due 2020 Underwriting Agreement (Filed With SEC on June 10, 2013)

ARRAY BIOPHARMA INC. TO WELLS FARGO BANK, NATIONAL ASSOCIATION Trustee Indenture Dated as of June 10, 2013 (Filed With SEC on June 10, 2013)

ARRAY BIOPHARMA INC. (Company) WELLS FARGO BANK, NATIONAL ASSOCIATION (Trustee) 3.00% Convertible Senior Notes due 2020 FIRST SUPPLEMENTAL INDENTURE Dated as of June 10, 2013 to... (Filed With SEC on June 10, 2013)

NINTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on June 10, 2013)

EMPLOYMENT AGREEMENT (Filed With SEC on May 7, 2013)

NONCOMPETE AGREEMENT (Filed With SEC on May 7, 2013)

THIRD AMENDMENT TO DRUG DISCOVERY AND DEVELOPMENT AGREEMENT (Filed With SEC on February 6, 2013)

EIGHTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on February 6, 2013)

AMENDMENT TO FACILITY AGREEMENTS (Filed With SEC on February 6, 2013)

18,000,000 Shares Array BioPharma Inc. UNDERWRITING AGREEMENT (Filed With SEC on November 9, 2012)

CERTIFICATE OF AMENDMENT TO AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ARRAY BIOPHARMA INC. (Pursuant to Section 242) (Filed With SEC on October 29, 2012)

ARRAY BIOPHARMA INC. DESCRIPTION OF PERFORMANCE BONUS PROGRAM (Filed With SEC on August 31, 2012)

SECOND AMENDMENT TO DRUG DISCOVERY AND DEVELOPMENT AGREEMENT (Filed With SEC on May 3, 2012)

EMPLOYMENT AGREEMENT (Filed With SEC on May 1, 2012)

NONCOMPETE AGREEMENT (Filed With SEC on May 1, 2012)

CONFIDENTIALITY AND INVENTIONS AGREEMENT (Filed With SEC on May 1, 2012)

20,000,000 Shares Array BioPharma Inc. UNDERWRITING AGREEMENT (Filed With SEC on February 9, 2012)

COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on November 2, 2011)

LICENSE AGREEMENT BY AND BETWEEN GENENTECH, INC., F. HOFFMANN-LA ROCHE, LTD AND ARRAY BIOPHARMA INC. (Filed With SEC on November 2, 2011)

ARRAY BIOPHARMA INC. DESCRIPTION OF PERFORMANCE BONUS PROGRAM (Filed With SEC on September 8, 2011)

ARRAY BIOPHARMA INC. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES B CONVERTIBLE PREFERRED STOCK PURSUANT TO SECTION 151 OF THE DELAWARE GENERAL... (Filed With SEC on May 3, 2011)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on May 3, 2011)

Form of Amendment No. 1 to Warrant to Purchase Common Stock of ARRAY BIOPHARMA INC. (Filed With SEC on May 3, 2011)

SIXTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on April 6, 2010)

COLLABORATIONAND LICENSE AGREEMENT (Filed With SEC on February 2, 2010)

ARRAY BIOPHARMAINC. DESCRIPTION OFPERFORMANCE BONUS PROGRAM (Filed With SEC on November 3, 2009)

FIFTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on October 5, 2009)

FACILITY AGREEMENT (Filed With SEC on September 30, 2009)

Warrantto Purchase Common Stock of ARRAYBIOPHARMA INC. (Filed With SEC on September 24, 2009)

$25,000,000 ARRAY BIOPHARMA INC. Common Stock Equity Distribution Agreement (Filed With SEC on September 18, 2009)

Warrant to Purchase Shares Warrant Number Warrant to Purchase Common Stock of ARRAY BIOPHARMA INC. (Filed With SEC on August 18, 2009)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on August 18, 2009)

FIRST AMENDMENT TO DRUGDISCOVERY AND DEVELOPMENT AGREEMENT (Filed With SEC on August 18, 2009)

FACILITYAGREEMENT (Filed With SEC on August 18, 2009)

ARRAY BIOPHARMAINC. DESCRIPTION OFPERFORMANCE BONUS PROGRAM (Filed With SEC on June 17, 2009)

FOURTH AMENDMENT TO DRUGDISCOVERY COLLABORATION AGREEMENT (Filed With SEC on November 4, 2008)

FIFTH AMENDMENT TO DRUGDISCOVERY COLLABORATION AGREEMENT (Filed With SEC on November 4, 2008)

Warrant toPurchase Common Stock of ARRAYBIOPHARMA INC. (Filed With SEC on May 5, 2008)

FACILITY AGREEMENT (Filed With SEC on May 5, 2008)

SECURITY AGREEMENT (Filed With SEC on May 5, 2008)

REGISTRATIONRIGHTS AGREEMENT (Filed With SEC on May 5, 2008)

DRUGDISCOVERY AND DEVELOPMENT AGREEMENT (Filed With SEC on November 6, 2007)

ARRAY BIOPHARMA INC. DESCRIPTION OF PERFORMANCE BONUS PROGRAM (Filed With SEC on October 5, 2007)

ARRAY BIOPHARMAINC. 7,000,000 Sharesof Common Stock ($0.001 par valueper Share) (Filed With SEC on May 2, 2007)

ARRAY BIOPHARMAINC. DESCRIPTION OFPERFORMANCE BONUS PROGRAM (Filed With SEC on November 6, 2006)

LEASE by and between BMR-3200 Walnut Street LLC, a Delaware limited liability company] and Array BioPharma Inc., a Delaware corporation (Filed With SEC on November 6, 2006)

LEASE by and between BMR-Trade Centre Avenue LLC, a Delaware limitedliability company and Array BioPharma Inc., a Delaware corporation (Filed With SEC on November 6, 2006)

AGREEMENTOF PURCHASE AND SALE (2600 and 2620 Trade CentreAvenue, Longmont, Colorado) (Filed With SEC on November 6, 2006)

ASSIGNMENT OF LONGMONT PURCHASE AGREEMENT (Filed With SEC on November 6, 2006)

SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT, CONSENT AND WAIVER (Filed With SEC on November 6, 2006)

AMENDED AND RESTATED ARRAY BIOPHARMA INC. STOCK OPTION AND INCENTIVE PLAN INCENTIVE STOCK OPTION AGREEMENT (Filed With SEC on September 1, 2006)

AMENDED AND RESTATED ARRAY BIOPHARMA INC. STOCK OPTION AND INCENTIVE PLAN NONQUALIFIED STOCK OPTIONAGREEMENT (Filed With SEC on September 1, 2006)

OPTION AGREEMENT (Filed With SEC on September 1, 2006)

ASSIGNMENT OF BOULDER OPTION AGREEMENT (Filed With SEC on September 1, 2006)

ASSIGNMENTAGREEMENT (Filed With SEC on September 1, 2006)

ADDENDUM #7 TO LEASEAGREEMENT (Filed With SEC on May 1, 2006)

SECOND AMENDMENT TO DRUGDISCOVERY COLLABORATION AGREEMENT (Filed With SEC on February 6, 2006)

DRUG DISCOVERY AGREEMENT (Filed With SEC on February 6, 2006)

FIRST AMENDMENT TO LOAN AND SECURITYAGREEMENT (Filed With SEC on February 6, 2006)

ADDENDUM#5 TO LEASE AGREEMENT (Filed With SEC on February 6, 2006)

AMENDMENT TO THE ARRAY BIOPHARMA INC. EMPLOYEE STOCK PURCHASE PLAN (as amended andrestated September 12, 2002, and as amended on April 29, 2004) (Filed With SEC on February 6, 2006)

FirstAmendment to the Amendedand Restated Deferred Compensation Plan of Array BioPharma Inc. (Filed With SEC on February 6, 2006)

DRUGDISCOVERY COLLABORATION AGREEMENT (Filed With SEC on September 13, 2005)

ADDENDUM #4 TO LEASE AGREEMENT (Filed With SEC on September 13, 2005)

ARRAY BIOPHARMA INC. DESCRIPTION OF PERFORMANCEBONUS PROGRAM (Filed With SEC on August 9, 2005)

Compensationfor Independent Directors on the Board of Directors of Array BioPharma Inc. (Filed With SEC on February 7, 2005)

DEFERRED COMPENSATION PLAN OF ARRAY BIOPHARMA INC. (Effective as of August 1, 2004) (Filed With SEC on November 1, 2004)

ARRAYBIOPHARMA INC. AMENDMENTTO EMPLOYEESTOCK PURCHASE PLAN (asamended and restated September 12, 2002) (Filed With SEC on May 6, 2004)

COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on February 2, 2004)

DRUG DISCOVERY COLLABORATION AGREEMENT BETWEEN GENENTECH, INC. AND ARRAY BIOPHARMA INC. (Filed With SEC on February 2, 2004)

EX-10.1 Lease Agreement (Filed With SEC on May 13, 2002)

Category

Industry

Companies

Contracts

ARRAY BIOPHARMA INC Contracts & Agreements